PIEPER STEVEN (Chief Financial Officer) reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/7/2025ACC: 0001867096-25-000012
Officer· Chief Financial Officer
Since Oct 2021
-32.06K
Net shares
Net seller
$115.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
32.06K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−32.06K
Price / share
$3.61
Trade value
$115.73K
% of position
2.2%
1/3/2025
1.44M→1.41M
Total
Net shares
−32.06K
Net value
-$115.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2025 | F · Tax Withholding | −32.06K | $3.61 | $115.73K | 2.2% | 1.44M | 1.41M |
| Total | −32.06K | -$115.73K | ||||||
Derivative Transactions0
No derivative transactions reported